INSMED INC
8-K, EX-99.1, 2000-11-08
PHARMACEUTICAL PREPARATIONS
Previous: INSMED INC, 8-K, 2000-11-08
Next: STRATEGIC PARTNERS SERIES, N-30D, 2000-11-08



<PAGE>

                                                                    EXHIBIT 99.1

For further information contact:

Sophia Twaddell
312.751.3738
[email protected]
----------------------



              Insmed Incorporated Announces Access Information for
             Presentation At Prudential Vector Healthcare Conference

        Company's Presentation at Prudential Vector Healthcare Conference
                 To Be Webcast Live on November 9 at 2:15 pm EST

          Richmond,  VA, November 8, 2000 - Insmed Incorporated (Nasdaq: INSM)
today announced access information for investors to listen to the company's
presentation at the Prudential Vector Healthcare Conference.

          The company's presentation will be delivered by Geoffrey Allan, PhD,
president and CEO, and will be webcast live at 2:15 p.m. EST on Thursday,
November 9.   Institutional clients of Prudential Securities will have access
through Prudential's proprietary institutional website.  Members of the general
public will have access to the audio webcast through Prudential Securities.com.
Those wishing to listen should click on the Healthcare Conference icon for a
schedule of presenting companies, then click on Insmed Incorporated to access
the audio presentation.  Slides of Dr. Allan's presentation will be available on
the "Investor Relations" page of Insmed's website at www.insmed.com for
approximately one week after the presentation.

About Insmed Incorporated

     Insmed Incorporated is a biopharmaceutical company focused on the discovery
and development of pharmaceutical products for the treatment of metabolic
diseases and endocrine disorders associated with insulin resistance.  Further
information is available at www.insmed.com.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission